(Q39844658)

15 September 2017

title

Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways (English)

1 reference

15 September 2017

1 reference

S Chung

1

1 reference

15 September 2017

M Furihata

2

1 reference

15 September 2017

K Tamura

3

1 reference

15 September 2017

M Uemura

4

1 reference

15 September 2017

Y Daigo

5

1 reference

15 September 2017

Y Nasu

6

1 reference

15 September 2017

T Miki

7

1 reference

15 September 2017

T Shuin

8

1 reference

15 September 2017

T Fujioka

9

1 reference

15 September 2017

Y Nakamura

10

1 reference

15 September 2017

H Nakagawa

11

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

32

1 reference

15 September 2017

page(s)

2849-2859

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.144

15 September 2017

exact match

0 references

cites work

Cell cycle and death control: long live Forkheads

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Isoform-specific differences in the potencies of murine protein kinase inhibitors are due to nonconserved amino-terminal residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Trends and patterns of prostate cancer: what do they suggest?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Akt-regulated pathways in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Regulatory subunits of PKA and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

The Akt pathway: molecular targets for anti-cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

PKB/AKT: functional insights from genetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Localized effects of cAMP mediated by distinct routes of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Dynamics of signaling by PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Analysis of PTEN and the 10q23 region in primary prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Prostate cancer epidemiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.144

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.144

1 reference

15 September 2017

1 reference